ANGLE plc

LSE:AGL.L

Sector

🏥 Health Care

Industries

🧬 Biotechnology

📊 Big Data

💻 Computers

🩺 Medical Instruments

💻 Telehealth

Location

United Kingdom

Market Cap

USD 33.05 M

Share Price

USD 0.10

Avg Daily Volume

1,244,720

Change (1 day)

3.81%

Change (1 year)

-41.26%

Change (YTD)

-20.10%

ANGLE plc Revenue Per Share for the year ending December 31, 2023: USD 0.01

ANGLE plc Revenue Per Share is USD 0.01 for the year ending December 31, 2023, a 108.94% change year over year. Revenue per share indicates revenue generated per share; higher ratios suggest stronger performance and value.

ANGLE plc Revenue Per Share for the year ending December 31, 2022 was USD 0.01, a -16.23% change year over year.
ANGLE plc Revenue Per Share for the year ending December 31, 2021 was USD 0.01, a 4.20% change year over year.
ANGLE plc Revenue Per Share for the year ending December 31, 2020 was USD 0.01, a -17.02% change year over year.
ANGLE plc Revenue Per Share for the year ending December 31, 2019 was USD 0.01, a 8.73% change year over year.

Quarterly
Annual
TTM

From:

To:

Zoom:

Key data

Date	Revenue Per Share	Free Cash Flow Per Share	Dividend Per Share	Debt to Equity Ratio

LSE: AGL.L

ANGLE plc

CEO	Mr. Andrew David William Newland ACA, Meng
IPO Date	March 17, 2004
Location	United Kingdom
Headquarters	Surrey Research Park
Employees	150
Sector	🏥 Health Care
Industries Biotechnology 📊 Big Data 💻 Computers 🩺 Medical Instruments 💻 Telehealth

Description

ANGLE plc, a medical diagnostic company, engages in developing cancer diagnostics products. The company develops and commercializes Parsortix cell separation system, which captures and harvests circulating tumor cells in metastatic breast cancer patient blood; and HyCEAD multiplex analysis system for routine and focused multiplex analysis of DNA, RNA or protein biomarkers. The company was founded in 1994 and is based in Guildford, the United Kingdom.